Ocudox Side Effects

Generic name: doxycycline

Medically reviewed by Drugs.com. Last updated on Apr 16, 2024.

Note: This document provides detailed information about Ocudox Side Effects associated with doxycycline. Some dosage forms listed on this page may not apply specifically to the brand name Ocudox.

Applies to doxycycline: oral capsule, oral capsule extended release, oral powder for suspension, oral syrup, oral tablet, oral tablet delayed release.

Serious side effects of Ocudox

Along with its needed effects, doxycycline (the active ingredient contained in Ocudox) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking doxycycline:

Other side effects of Ocudox

Some side effects of doxycycline may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For Healthcare Professionals

Applies to doxycycline: injectable powder for injection, oral capsule, oral delayed release capsule, oral delayed release tablet, oral kit, oral powder for reconstitution, oral syrup, oral tablet, oral and topical kit.

Nervous system

• Very common (10% or more): Headache (up to 26%)
• Common (1% to 10%): Sinus headache
• Rare (0.01% to 0.1%): Bulging fontanels (in infants), benign intracranial hypertension (pseudotumor cerebri [symptoms include blurred vision, scotomata, diplopia]), tinnitus
• Frequency not reported: Hypoesthesia, increased intracranial pressure, paresthesia, somnolence, stupor, taste loss, drowsiness, amnesia, paresthesias of body areas exposed to sunlight, phrenic nerve paralysis after sclerotherapy
• Postmarketing reports: Pseudotumor cerebri, headache, dizziness^[Ref]

Benign intracranial hypertension resulting in permanent loss of vision has been reported.

A 70-year-old female patient with no significant medical history suddenly developed a severe headache followed by vomiting about 15 minutes after the initial dose of this drug. The patient also experienced memory dysfunction; she could not remember the events of the afternoon prior to the dose of this drug and could not retain the information after she was reminded. The incident lasted about 30 minutes and she was transported to the hospital for further evaluation. No further cause, such as intoxication or trauma, could be elicited. Once at the hospital, the patient was able to remember the events of the afternoon and could retain new information, but amnesia regarding the events of the 30 minutes following the onset of the headache persisted. The patient's laboratory results, computerized tomography scan, MRI scan, cerebrospinal fluid, and electroencephalogram showed no pathology. When the patient was discharged 2 days later, the amnesia for the 30 minutes continued. After elimination of other symptomatic causes, the amnesia was concluded to be due to this drug because of the close relation of the dose and the onset of symptoms.^[Ref]

Other

• Very common (10% or more): Common cold (up to 22%), influenza symptoms (up to 11%)
• Common (1% to 10%): Injury/accidental injury, pain, infection, fungal infection, influenza
• Rare (0.01% to 0.1%): Candida infection/candidiasis, flushing, retrosternal pain
• Frequency not reported: Malaise, overgrowth of nonsusceptible organisms (superinfection)
• Postmarketing reports: Asthenia^[Ref]

Gastrointestinal

• Very common (10% or more): Nausea (up to 13.4%)
• Common (1% to 10%): Nausea/vomiting, toothache, tooth disorder, dyspepsia, diarrhea, periodontal abscess, acid indigestion, upper abdominal pain, abdominal distention, abdominal pain, stomach discomfort, dry mouth
• Uncommon (0.1% to 1%): Gum pain, heartburn/gastritis
• Rare (less than 0.1%): Glossitis, dysphagia, enterocolitis, inflammatory lesions (with candidal/monilial overgrowth) in the anogenital region, esophagitis, esophageal ulcerations, pancreatitis, pseudomembranous colitis, Clostridium difficile colitis, stomatitis
• Frequency not reported: Clostridium difficile-associated diarrhea, esophageal irritation, ulceration, epigastric burning, black hairy tongue, tooth discoloration/adult tooth staining, vomiting, enamel hypoplasia, staphylococcal enterocolitis
• Postmarketing reports: Bloody diarrhea, colitis, constipation, superficial tooth discoloration^[Ref]

Numerous cases of esophageal ulceration have been reported. In most cases, the patients had taken their medication at bedtime, usually without enough liquid. Patients often presented with severe retrosternal pain and difficulty swallowing. Ulcerations generally resolved within a week after discontinuing the drug. In 1 case report, severe hiccups of 4-day duration associated with esophagitis followed the first dose of this drug.

Esophagitis and esophageal ulcerations have been reported in patients taking the capsule or tablet formulations of tetracycline-class antibiotics. Most of these patients took the drug immediately before going to bed.^[Ref]

Musculoskeletal

• Common (1% to 10%): Joint pain/arthralgia, back pain/back ache
• Uncommon (0.1% to 1%): Muscle pain/myalgia^[Ref]

Respiratory

• Common (1% to 10%): Nasopharyngitis, sore throat, sinus congestion, coughing, sinusitis, bronchitis, nasal congestion, pharyngolaryngeal pain
• Frequency not reported: Bronchospasm

Dermatologic

• Common (1% to 10%): Rash (including maculopapular rash, erythematous rash), photosensitivity reaction/dermatitis
• Rare (0.01% to 0.1%): Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, photoonycholysis, drug reaction with eosinophilia and systemic symptoms (DRESS)
• Frequency not reported: Nail discoloration, phototoxicity, photoallergic reaction, morbilliform rash, onycholysis, pustular rash
• Postmarketing reports: Pruritus, urticaria
• Tetracyclines:
• -Frequency not reported: Hyperpigmentation^[Ref]

Common (1% to 10%): Rash (including maculopapular rash, erythematous rash), photosensitivity reaction/dermatitis
Rare (0.01% to 0.1%): Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, photoonycholysis, drug reaction with eosinophilia and systemic symptoms (DRESS)
Frequency not reported: Nail discoloration, phototoxicity, photoallergic reaction, morbilliform rash, onycholysis, pustular rash
Postmarketing reports: Pruritus, urticaria

Tetracyclines:
Frequency not reported: Hyperpigmentation^[Ref]

Genitourinary

• Common (1% to 10%): Menstrual cramps, bacterial vaginitis, vulvovaginal mycotic infection
• Uncommon (0.1% to 1%): Vaginal infection
• Frequency not reported: Vaginal itch, vaginitis
• Postmarketing reports: Vaginal candidiasis/moniliasis, anogenital moniliasis^[Ref]

Cardiovascular

• Common (1% to 10%): Hypertension, increased blood pressure
• Frequency not reported: Phlebitis (with IV administration)

Hepatic

• Common (1% to 10%): Increased AST
• Rare (0.01% to 0.1%): Abnormal hepatic function, hepatic failure, hepatitis, hepatotoxicity, jaundice
• Frequency not reported: Acute hepatocellular injury, cholestatic reactions, cholestatic hepatitis, fatty liver degeneration, transient increases in liver function tests^[Ref]

Metabolic

• Common (1% to 10%): Increased blood LDH, increased blood glucose
• Rare (0.01% to 0.1%): Decreased appetite, porphyria
• Frequency not reported: Hypoglycemia, anorexia^[Ref]

Hypoglycemia in a nondiabetic patient has been reported.^[Ref]

Psychiatric

• Common (1% to 10%): Anxiety
• Frequency not reported: Confusion, depression, hallucination

Hypersensitivity

• Common (1% to 10%): Anaphylactic reaction (including angioedema, exacerbation of systemic lupus erythematosus, pericarditis, hypersensitivity, serum sickness, Henoch-Schonlein purpura, hypotension, dyspnea, tachycardia, peripheral edema, urticaria)
• Frequency not reported: Hypersensitivity reactions (including urticaria, angioneurotic edema, anaphylactic shock, anaphylaxis, anaphylactoid reactions, anaphylactoid purpura, serum sickness, hypotension, pericarditis, exacerbation of systemic lupus erythematosus, dyspnea, peripheral edema, tachycardia)
• Postmarketing reports: Mild allergic reactions^[Ref]

Hematologic

• Rare (0.01% to 0.1%): Hemolytic anemia, thrombocytopenia, neutropenia, eosinophilia
• Frequency not reported: Increased prothrombin time, leukopenia, thrombocytopenic purpura^[Ref]

Renal

• Rare (0.01% to 0.1%): Increased BUN/blood urea (dose-related)
• Frequency not reported: Acute renal failure^[Ref]

Endocrine

• Rare (0.01% to 0.1%): Microscopic brown-black discoloration of the thyroid gland^[Ref]

The long-term use of tetracyclines has been associated with microscopic brown-black discoloration of the thyroid gland; abnormal thyroid function has not been reported.^[Ref]

Ocular

• Frequency not reported: Diplopia, papilledema, loss of vision (associated with drug-induced benign intracranial hypertension), conjunctivitis, periorbital edema^[Ref]

Immunologic

Tetracyclines:
Frequency not reported: Autoimmune syndromes

Frequently asked questions

• What are the most common skin conditions? (with photos)
• Is Doxycycline safe for dogs? Uses, dosage, side effects
• Should doxycycline be taken with food?
• What are the best antibiotics for pneumonia?
• What is the best antibiotic to treat a sinus infection?
• Doxycycline for STDs
• How long after stopping doxycycline can I drink alcohol?
• Does Doxycycline make you tired?
• What causes black hairy tongue?

Further information

Ocudox side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer